Basic Information
LncRNA/CircRNA Name | HIF1A-AS2 |
Synonyms | HIF1A-AS2, 3'aHIF-1A, aHIF |
Region | GRCh38_14:61715558-61751097 |
Ensemble | ENSG00000258667 |
Refseq | NR_045406 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qRT-PCR, Western blot, Luciferase reporter assay, RIP |
Sample | human CRC tissues, Human CRC cell lines (SW620, DLD-1, HT-29, HCT116) |
Expression Pattern | up-regulated |
Function Description | immunofluorescence, all those assays reflected a fact that as a ceRNA, HIF1A-AS2 could directly bind with miR-129-5p, and could positively affect cell proliferation, invasion and EMT formation by regulation of the expression of miR-129-5p and DNMT3A. |
Pubmed ID | 29278853 |
Year | 2017 |
Title | LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A. |
External Links
Links for HIF1A-AS2 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |